NPC Institute Survey: Affordability of Medications

JavaScript isn't enabled in your browser, so this file can't be opened. Enable and reload.

The purpose of the survey is to gather a consensus regarding attitudes of pharma industry personnel toward emerging trends in the life sciences. Data collected with this form will be kept confidential and anonymized.

The findings will be used to advance discussions and help determine policy recommendations.

Upon distribution of the white paper, the network will also be invited to join the Winter 2024 NPCI Webinar on Feb. 28, 2024, which will feature two industry leaders debating the issue of medication affordability.

In light of recent moves by U.S. institutional buyers to obtain lower-cost medications from Canadian suppliers, should such buyers be able to enter purchasing contracts with medication suppliers outside of their nation of operation?

Yes

Clear selection

How might this sort of international purchasing agreement impact medication affordability broadly? Please check all that apply.

Have short-term effects

Have long-term effects

Make medication more affordable everywhere

Make medication less affordable everywhere

Improve affordability in the U.S., while reducing affordability in Canada

Other

Why do you feel this way? Please answer below.

How concerned are you about the affordability of medications in your markets?

Not at all concerned

Highly concerned

Clear selection

Which stakeholders would you say have the greatest control over medication affordability? Please choose your top three from this list.

Regulators

Public insurers

Private insurers

Drug manufacturers

Supply chain

Research groups

Other:

What policies could regulators adopt that would improve medication affordability, beyond subsidizing insurers?

We welcome any additional thoughts and comments on the affordability of medications

Clear form

Never submit passwords through Google Forms.

This form was created inside of Chronicle Companies. Report Abuse

Forms